Avalere recently assembled experts in the field of patient-centered health technology assessment to discuss evidence strategy, health equity, caregiver involvement, and downstream impacts on care delivery. 📽 Watch the full discussion here: https://lnkd.in/eRmFB-vP Featuring Laura T. Housman, MPH, MBA, DrPH(c), Joey Mattingly, Nikki Martin, Claire Saxton, Mina Alsaraf Allo, and Shelby Harrington #patientpreferences #patientperspective #patients #healthcare #HTA #healthtechnologyassessment
Avalere
Business Consulting and Services
Washington, DC 15,024 followers
Part of Avalere Health
About us
Avalere, part of Avalere Health , is a strategic advisory company whose core purpose is to create innovative solutions to complex healthcare problems. Based in Washington, D.C., the firm delivers actionable insights, business intelligence tools, and custom analytics for leaders in healthcare business and policy. Avalere's experts span 200+ staff drawn from Fortune 500 healthcare companies, the federal government, and top consultancies and nonprofits. The firm offers advisory services on a wide range of healthcare business issues affecting healthcare companies. Avalere’s focus on strategy is supported by a rigorous, in-house analytic research group that uses public and private data to generate quantitative insight. Through events, publications and interactive programs, Avalere insights are accessible to a broad range of customers. Avalere sits within the Policy, Access, Value, and Evidence discipline of Avalere Health and collaborates with colleagues across the firm to offer actionable, thoughtful guidance to clients. Visit AvalereHealth.com to learn about our full Policy, Access, Value, and Evidence offering.
- Website
-
http://www.avalere.com
External link for Avalere
- Industry
- Business Consulting and Services
- Company size
- 201-500 employees
- Headquarters
- Washington, DC
- Type
- Public Company
- Specialties
- Health insurance and reform, Evidence-based medicine, Reimbursement and product commercialization, Health economics and outcome research, Healthcare networks, Post-acute and long-term care, Data analytics and modeling, and Financial Services
Locations
-
Primary
Get directions
1201 New York Ave NW
Suite 1000
Washington, DC 20005, US
Employees at Avalere
-
Rob M. Carter
Practice Director of Avalere’s division that serves healthcare investors
-
Shalini Parekh
Managing Director at Avalere Health
-
Milena Sullivan
Managing Director, Healthcare Policy Practice at Avalere Health
-
John Neal
Managing Director @ Avalere Health | MBA, Market Access Strategy
Updates
-
RESOURCE ROUNDUP! This month, #AvalereExperts are publishing analyses and research findings on a wide variety of topics, including #vaccine policy, #oncology drug coverage, #breastcancer screening recommendations, and more. Read our latest publications: 📰 Health Plans 2030: Evolving Operational Approaches: https://lnkd.in/ecYKtZCH 📰 Breast Cancer Screening Recommendations May Drive Inequities: https://lnkd.in/e6PW9td3 📰 State Statute Oncology Drug Coverage Report: https://lnkd.in/ezz5zfgD 📰 Adult Seasonal Combination Respiratory Vaccines: Policy Considerations: https://lnkd.in/eeyAWaGp 📰 Five Data Strategy Questions Pharma Should Ask For 2025: https://lnkd.in/euY35wPi
-
In April, the U.S. Preventive Services Task Force issued new breast cancer screening recommendations. In a new #AvalereInsight, Amanda Jourgensen, Nya Barrow, MPH, and Olivia Hunt discuss how these updated recommendations may not address racial disparities in screening, diagnosis, and outcomes: https://lnkd.in/e6PW9td3 #breastcancer #breastcancerscreening #preventiveservices
-
-
CMS recently released a rule on health insurers' use of #artificialintelligence, algorithms and other tools. #AvalereExpert Michael Lutz spoke with MMIT (Managed Markets Insight & Technology)'s AISHealth about what the new regulations mean for federal oversight and health plans' strategy: https://lnkd.in/ebg_5pVg
-
-
The #IRA requires that when a 340B-eligible drug is dispensed to a patient who is eligible for a maximum fair price discount, the manufacturer provide the lower of the two discounted prices, creating the possibility for duplicate discounts. How can #lifesciences manufacturers assess and reduce their risk of duplicate discounts? See how we tackled this question and others: https://lnkd.in/eShTw9PQ #InflationReductionAct #drugpricing #340B #340Bdrugdiscountprogram #MFP #maximumfairprice #healthpolicy #drugpricing
-
-
Happy #WomensHealthWeek! At Avalere, subject matter experts like President Sarah Alwardt work closely with women's health stakeholders to drive access to high-quality care that meets patients' unique needs, preferences, and priorities. Read our analyses and research findings on women's health and related policies: https://lnkd.in/eFrc2RBN #womenshealth #AvalereinAction #healthpolicy #patients #patientpreferences
-
-
Avalere's Women's Health Working Group is excited to announce a series of thought pieces related to #womenshealth in acknowledgement of #WomensHealthWeek in the United States. Stay tuned over the next few weeks connect with us to learn how we can support your organization's work related to women's health: https://lnkd.in/eWHHXKNx Shelby Harrington, Shareef Ghanem, Robin Duddy-Tenbrunsel, Jessica Cortez, CPB, Amy Schroeder, Margia Argüello MSc, MBA, Pranathi S., Jasmine Nicole Namata, Jenna Ivan, Micki Leonard, Dylan Davis, PhD, Sally Hwang
-
INTRODUCING HEALTH PLANS 2030: Our new series, Health Plans 2030, details #AvalereExperts' thinking on how the health insurance market will shift over the next six years and what plans should consider preparing for now. Read the first installment on how plans can evolve their approaches to provider contracting and utilization management for the future: https://lnkd.in/ecYKtZCH #healthplans #healthinsurance #healthpolicy #healthcare
-
-
💼 NOW HIRING! 💼 Are you an early- to mid-career #healthpolicy professional interested in finding innovative solutions to complex #healthcare problems? Apply today: Consultant II, Vaccines Policy & Access: https://lnkd.in/egSi4Qjc Senior Associate, Policy Analytics: https://lnkd.in/e_MWk9bQ State Policy Senior Associate: https://lnkd.in/gCim4irJ #healthpolicyjobs
-
Read the latest from #AvalereExperts on vaccine policy! Our newest white paper delves into strain selection, ACIP recommendation, and coverage and reimbursement of adult combination vaccines in development: https://lnkd.in/eeyAWaGp #vaccine #vaccinepolicy #preventivecare
If there was a way for you to get fewer vaccines, and still be protected against infectious diseases, wouldn't you want to be able to take advantage of that? 💉 As these types of combination vaccines work through R&D pipelines and become available, there are several barriers in current systems that could impede access. Our Avalere #Vaccines team examined potential barriers related to approval, recommendation development, and coverage/reimbursement that could impact patient access. We're constantly working to strategically stay ahead of headwinds and tailwinds that help people get vaccinated and encourage you to reach out if this is something you're thinking about as well! To see our full report: bit.ly/4dqme8n